TL;DR
- An FDA Import Alert is a public notice that a specific product, manufacturer, or shipper "appears" to violate FDA law, issued under the appearance standard in Section 801 of the Food, Drug & Cosmetic Act (21 USC 381) (FDA, Import Alerts)
- Once a firm is on an Import Alert's Red or Yellow list, every future shipment is subject to Detention Without Physical Examination (DWPE) — FDA can detain and refuse the product without testing or inspecting the actual shipment first
- DWPE is triggered by "appearance," not proof — the importer, not FDA, carries the burden of showing the specific shipment doesn't have the violation the alert describes
- An Import Alert can predate a Warning Letter by weeks or months, since the two enforcement tools move on separate tracks inside FDA
- Getting removed from an Import Alert requires the firm to petition FDA directly, following the specific "Guidance" instructions published inside that individual alert
What is an FDA Import Alert, exactly?
An Import Alert is FDA's way of telling its own field staff, and the public, that a product or firm "appears" to violate the law — before FDA has tested or examined the actual shipment sitting at the border. That single word, appears, does a lot of work. It comes straight from Section 801 of the Food, Drug & Cosmetic Act, codified at 21 USC 381, which gives FDA authority to refuse products that appear to violate FDA laws and regulations. FDA calls this the "appearance standard" (FDA, Import Alerts).
Practically, an Import Alert is a list. FDA maintains hundreds of them, organized by product type, violation category, or specific firm. Each one names the reason for the alert, the products and firms affected, and the laws or regulations that appear to have been violated.
Here's the part compliance teams miss. An Import Alert is not a Warning Letter, and it doesn't wait for one. FDA can add a firm to an Import Alert based on an inspection finding, a sample analysis, or a pattern of violative imports — independent of whether or when a Warning Letter follows. In practice, firms often see the Import Alert land first.
What does "Detention Without Physical Examination" actually mean?
DWPE is the enforcement mechanism attached to an Import Alert. Once a firm or product is subject to DWPE, FDA can detain a shipment at the border and refuse it entirely, without physically examining or lab-testing that specific shipment. The appearance of a violation, from a prior inspection or prior shipment, is enough to trigger detention on the next one.
Quick refresher on how the lists work, because this trips people up:
- Red or Yellow list — firms and products named here ARE subject to DWPE under that alert
- Green list — firms and products named here are EXEMPT from DWPE under that same alert
- Not listed at all — for a Red/Yellow-list alert, absence means you're not subject to DWPE under it; for a Green-list alert, absence means you ARE subject to DWPE
That third bullet is counterintuitive enough that it's worth reading twice. The list type changes what "not on the list" means.
Who has to prove what, once a shipment is detained?
This is the part that actually costs companies money and time. Once a product is detained under an Import Alert, the importer has to prove a negative: that this specific shipment does not have the violation described in the alert. FDA doesn't have to prove the shipment is bad. The importer has to prove it isn't.
Each Import Alert has its own "Guidance" section spelling out what evidence FDA will accept — private lab analysis, updated certificates, corrective action documentation, or other proof specific to that alert's violation type. There's no universal checklist. What satisfies one alert's guidance won't necessarily satisfy another's, even for the same company.
How does an Import Alert connect to a Warning Letter?
They're related but not sequential in a fixed order. A Warning Letter is a formal statement, from FDA district or center management, that specific inspection findings constitute violations of the law. An Import Alert is a border-enforcement listing tied to the appearance standard. FDA can issue either one without the other, and the timing between them varies by case.
When a facility already carries a documented history — a prior Warning Letter, a prior Import Alert, unresolved complaints — a new Import Alert tends to get read by compliance teams as confirmation of an existing pattern, not a standalone event. That's a judgment call worth making explicitly in your own vendor risk reviews, rather than treating each enforcement action as an isolated data point.
How does a firm get removed from an Import Alert?
There's no automatic expiration. A firm has to actively petition FDA for removal, and the process is specific to each individual alert — which is why FDA publishes a "Guidance" section inside every alert rather than one universal removal procedure. Generally, that means demonstrating to FDA, with evidence, that the firm no longer has the violation the alert describes: corrected manufacturing conditions, validated processes, private lab results showing compliance, or whatever else that specific alert's guidance requires.
Until FDA formally removes the listing, DWPE stays in effect. A firm that believes it's fixed the underlying problem is still subject to detention at the border until FDA agrees, in writing, that the removal criteria are met.
FAQ
Is an Import Alert the same as an FDA Warning Letter?
No. A Warning Letter is a formal notice from FDA management that specific inspection findings violate the law. An Import Alert is a separate border-enforcement listing, issued under the appearance standard in Section 801 of the FD&C Act, that triggers Detention Without Physical Examination. FDA can issue one without the other.
What does DWPE mean for a company's shipments?
Once a firm or product is subject to Detention Without Physical Examination, FDA can detain and refuse shipments at the border without testing or physically examining that specific shipment. The burden shifts to the importer to show the shipment doesn't have the violation the alert describes.
Can a company be on an Import Alert without ever getting a Warning Letter?
Yes. The two enforcement actions run on separate tracks. An Import Alert can be based on inspection findings, sample results, or a pattern of violative imports, independent of whether FDA also pursues a Warning Letter.
How long does a firm stay on an Import Alert?
There's no fixed expiration. A firm remains subject to DWPE until it successfully petitions FDA for removal, following the specific guidance published inside that individual alert, and FDA agrees the removal criteria have been met.
Related reading
- Excelvision (Fareva) FDA Warning Letter 726714 — Import Alert 66-40 predated this letter
- Form 483 vs. FDA Warning Letter
- How long to respond to a Warning Letter
- Search the Warning Letter database →
See what a compliance-ready enforcement brief looks like — sample →
Founding rate: 6 of 10 Founding spots left at $50/mo →
Sources: FDA, Import Alerts, Federal Food, Drug & Cosmetic Act Section 801, 21 USC 381. Byline: The Argus Regulatory Analysis Team. Published 2026-07-08.

